Europe bioprocess technology market was valued at $6.56 billion in 2023 and will grow by 13.7% annually over 2023-2033. The growth is driven an increasing prevalence of chronic diseases, the widespread use of bioprocess technology, rising expenditures on R&D in the biotechnology sector, ongoing technological advancements, and a rising number of new drug production and launches.
Highlighted with 39 tables and 61 figures, this 133-page report "Europe Bioprocess Technology Market 2023-2033 by Product (Instruments, Consumables and Accessories), Process (Upstream, Downstream), Procedure, Application (Recombinant Proteins, Antibiotics, Biosimilars, mAbs, Others), End User (Biopharma Companies, CMOs, Institutes, CROs), and Country: Trend Forecast and Growth Opportunity" is based on comprehensive research of the entire Europe bioprocess technology market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2021-2023 and provides a forecast from 2024 till 2033 with 2023 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year, and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter's Fiver Forces
The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Europe bioprocess technology market in every aspect of the classification from perspectives of Product, Process, Procedure, Application, End User, and Country.
Based on Product, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2023-2033 included in each section.
• Instruments
o Bioprocess Analyzers
o Osmometers
o Bioreactors
o Incubators
o Other Instruments
• Consumables and Accessories
o Culture Media
o Reagents
o Other Consumables and Accessories
Based on Process, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2023-2033 included in each section.
• Upstream Bioprocessing
• Downstream Bioprocessing
By Procedure, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2023-2033 included in each section.
• Cell Culture
• Cell Expansion
• Flow Cytometry
• Cell Line Development
• Cell Counting
• Biologics Safety Testing
• Tangential Flow Filtration (TFF)
• Other Procedures
By Application, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2023-2033 included in each section.
• Recombinant Proteins
• Antibiotics
• Biosimilars
• Monoclonal Antibodies (mAbs)
• Other Applications
By End User, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2023-2033 included in each section.
• Biopharmaceutical Companies
• Contract Manufacturing Organizations (CMOs)
• Academic Research Institutes
• Contract Research Organizations (CROs)
• Food & Feed Industry
• Other End Users
Geographically, the following national/local markets are fully investigated:
• Germany
• UK
• France
• Spain
• Italy
• Netherlands
• Rest of Europe (further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2023-2033. The breakdown of national markets by Product, Application, and End User over the forecast years are also included.
The report also covers the current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Advanced Instruments LLC
Agilent Technologies, Inc.
Becton Dickinson and Company
Bio-rad Laboratories Inc.
Boehringer Ingelheim International GmbH
Catalent Inc.
Charles River Laboratories
Corning Inc.
Danaher Corporation
Elitechgroup Inc. (gonotec Gmbh)
Eppendorf Se
F. Hoffmann-la Roche Ltd.
Fujifilm Healthcare Americas Corporation
GE Healthcare (General Electric Company)
Getinge Ab
Koninklijke Philips N.V.
Lonza Group Ag
Merck Kgaa
Repligen Corp.
Sartorius Group
STADA Arzneimittel AG
Thermo Fisher Scientific Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year, and the forecast covers at least 5 years over the base year.)
1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of Market Research Methodology 11
1.2.2 Market Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 13
1.2.6 Market Size/Share Estimation 14
1.2.7 Research Limitations 15
1.3 Executive Summary 16
2 Market Overview and Dynamics 19
2.1 Market Size and Forecast 19
2.1.1 Impact of COVID-19 on World Economy 20
2.1.2 Impact of COVID-19 on the Market 24
2.1.3 Impact of Russia-Ukraine Conflict 26
2.1.4 Impact of Israel-Palestine War 28
2.2 Major Growth Drivers 29
2.3 Market Restraints and Challenges 34
2.4 Emerging Opportunities and Market Trends 37
2.5 Porter's Fiver Forces Analysis 41
3 Segmentation of Europe Market by Product 45
3.1 Market Overview by Product 45
3.2 Instruments 47
3.2.1 Bioprocess Analyzers 49
3.2.2 Osmometers 50
3.2.3 Bioreactors 51
3.2.4 Incubators 52
3.2.5 Other Instruments 53
3.3 Consumables and Accessories 54
3.3.1 Culture Media 56
3.3.2 Reagents 57
3.3.3 Other Consumables and Accessories 58
4 Segmentation of Europe Market by Process 59
4.1 Market Overview by Process 59
4.2 Upstream Bioprocessing 61
4.3 Downstream Bioprocessing 62
5 Segmentation of Europe Market by Procedure 63
5.1 Market Overview by Procedure 63
5.2 Cell Culture 65
5.3 Cell Expansion 66
5.4 Flow Cytometry 67
5.5 Cell Line Development 68
5.6 Cell Counting 69
5.7 Biologics Safety Testing 70
5.8 Tangential Flow Filtration (TFF) 71
5.9 Other Procedures 72
6 Segmentation of Europe Market by Application 73
6.1 Market Overview by Application 73
6.2 Recombinant Proteins 75
6.3 Antibiotics 76
6.4 Biosimilars 77
6.5 Monoclonal Antibodies (mAbs) 78
6.6 Other Applications 79
7 Segmentation of Europe Market by End User 80
7.1 Market Overview by End User 80
7.2 Biopharmaceutical Companies 82
7.3 Contract Manufacturing Organizations (CMOs) 83
7.4 Academic Research Institutes 84
7.5 Contract Research Organizations (CROs) 85
7.6 Food & Feed Industry 86
7.7 Other End Users 87
8 European Market 2023-2033 by Country 88
8.1 Overview of European Market 88
8.2 Germany 91
8.3 U.K. 93
8.4 France 95
8.5 Spain 97
8.6 Italy 99
8.7 Netherlands 101
8.8 Rest of European Market 103
9 Competitive Landscape 105
9.1 Overview of Key Vendors 105
9.2 New Product Launch, Partnership, Investment, and M&A 109
9.3 Company Profiles 110
Advanced Instruments LLC 110
Agilent Technologies, Inc. 112
Becton Dickinson and Company 113
Bio-rad Laboratories Inc. 114
Boehringer Ingelheim International GmbH 115
Catalent Inc. 116
Charles River Laboratories 117
Corning Inc. 118
Danaher Corporation 119
Elitechgroup Inc. (gonotec Gmbh) 120
Eppendorf Se 121
F. Hoffmann-la Roche Ltd. 122
Fujifilm Healthcare Americas Corporation 123
GE Healthcare (General Electric Company) 124
Getinge Ab 125
Koninklijke Philips N.V. 126
Lonza Group Ag 127
Merck Kgaa 128
Repligen Corp. 129
Sartorius Group 130
STADA Arzneimittel AG 131
Thermo Fisher Scientific Inc. 132
RELATED REPORTS 133
The Restaurant Technology Solutions Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, man...
The Distributed Renewable Energy Generation Technology Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competi...
The Advertising Technology Service Solutions Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive lands...
The Palm Vein Recognition Technology Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, ma...
The Molded Interconnect Substrate Technology Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive lands...
The Speech Synthesis Technology Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufac...
The Industrial Methanation Technology Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, m...
Market Overview
The Europe Vanadium Market is poised for significant growth from 2024 to 2034, driven by increasing demand across diverse industries such as iron and steel production, energy storage, and chemicals. The market is expected to reach USD XX.XX billion by 2034, expanding at ...
Market Overview
The Europe Vascular Closure Devices Market is poised for significant growth from 2024 to 2034, driven by advancements in minimally invasive procedures, increasing procedural volumes, and a growing preference for vascular closure solutions that enhance patient outcomes. T...
Market Overview
The Europe Nuclear Medicine Market is expected to witness substantial growth from 2024 to 2034, driven by advancements in nuclear imaging technology, increasing demand for early and accurate diagnosis, and the growing prevalence of chronic diseases such as cancer and car...